CLBCLBEnergy · Oil & Gas Equipment & Services

CLB Stock Forecast: Core Laboratories, Inc. Price Predictions for 2026-2027

Last close, 16 Nov 2026
$8.45
−7.24% on the day

The 3 Wall Street analysts covering Core Laboratories, Inc. hold a median 12-month price target of $13 — +53.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 38 of 100 as at 14 Nov 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$417.4M
Ticker Nerd rank
38/ 100
Median analyst target
$13
Analysts covering
3
Revenue$124.6M−4.3% y/y
Operating income$8.5M
Net income$5.8M
Free cash flow$2.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−6.4%
1M
−15.4%
YTD
−47.1%
1Y
−44.9%
From 52W high
−56.9%
From 52W low
0.0%
$8
$20
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CLB stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Core Laboratories, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Nov 2026
38/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
87
Revisions
55
Accruals
55
Size
54
Value
53
Quality
34
Volatility
32
Momentum
20
Growth
17

Issuance (87): The share count has been shrinking and the company is not leaning on new borrowing.

Growth (17): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

CLB stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CLB, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$15$20Jan 26Apr 26Jul 26Oct 26CLBHigh $21Median $13Low $11

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
2 Buy0 Hold1 Sell
Low $11Median $13High $21

The green dot is the last close — the median target sits +53.8% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 8 moved it down.

DateFirmActionRatingTarget
16 July 2025StifelMaintainsHold$13 → $12
13 May 2025CitigroupMaintainsNeutral—
15 Apr 2025StifelMaintainsHold—
12 Mar 2025CitigroupUpgradeNeutral—
20 Feb 2025CitigroupMaintainsSell—
31 Oct 2024CitigroupMaintainsSell—
26 July 2024StifelMaintainsHold$18 → $22
15 July 2024B of A SecuritiesMaintainsUnderperform$16 → $15
15 July 2024Piper SandlerMaintainsNeutral$18 → $17
26 Apr 2024StifelMaintainsHold$17 → $18
15 Apr 2024B of A SecuritiesMaintainsUnderperform$17 → $16
5 Feb 2024StifelMaintainsHold$21 → $17
29 Jan 2024StifelMaintainsHold$23 → $21
18 Sept 2023CitigroupMaintainsSell$21 → $20
31 July 2023Piper SandlerMaintainsNeutral$19 → $21
30 June 2023CitigroupDowngradeSell$22 → $21
1 May 2023Piper SandlerMaintainsNeutral$18 → $19
28 Apr 2023StifelMaintainsHold$24 → $25
18 Apr 2023B of A SecuritiesDowngradeUnderperform$22
7 Feb 2023CitigroupMaintainsNeutral$21 → $26

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CLB appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

CLB vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 16 Nov 2026, Core Laboratories, Inc. returned −44.9% against +13.5% for the S&P 500, dividends included.

CLB vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140Jan 26Apr 26Jul 26Oct 26CLBS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CLB analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
−6.2%
Analysts raising
1
Analysts cutting
0
Fundamentals

Core Laboratories, Inc. (CLB) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
26.8×

Cheaper than 28% of US stocks

Price / sales
0.8×

Cheaper than 71% of US stocks

Price / book
1.5×

Cheaper than 52% of US stocks

EV / EBITDA
10.5×

Cheaper than 35% of US stocks

Growth & margins
Revenue growth (YoY)
−1.8%

Higher than 25% of US stocks

Earnings growth (YoY)
−61.8%

Higher than 8% of US stocks

Gross margin
15.6%

Higher than 15% of US stocks

Operating margin
7.5%

Higher than 61% of US stocks

Net margin
3.0%

Higher than 54% of US stocks

Returns & dividend
Return on equity
5.6%

Higher than 54% of US stocks

Return on assets
4.1%

Higher than 71% of US stocks

Dividend yield
0.4%

Higher than 65% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Core Laboratories, Inc. (CLB) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Core Laboratories, Inc. has a market value of $417.4M and an enterprise value of $564.2M.

  • Revenue in the twelve months to 30 June 2026: $519.2M. The latest quarter shrank 1.8% year on year.

  • Net income over the same four quarters: $24.7M, a 4.8% net margin.

  • Diluted earnings per share, trailing twelve months: $0.55.

  • Free cash flow in the twelve months to 30 June 2026: $10.7M, after $17.3M of capital spending.

  • Core Laboratories, Inc. spent $14.4M on share buybacks and $1.9M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 45.9M.

  • Trailing P/E: 26.8×; forward P/E: 13.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.44%, paying out 12% of earnings.

  • Core Laboratories, Inc. employs 3,300 people — $157K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 16 Nov 2026

Data provided by Twelve Data

Peers

CLB vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelOil & Gas Equipment & Services
CompanyMarket capTKN rank
CLBCore Laboratories, Inc.$417.4M38
NGSNatural Gas Services Group, Inc.$383.1M41
OISOil States International, Inc.$516.0M56
HMHHMH Holding, Inc.$531.0M16
ACDCProFrac Holding Corp.$573.7M32
RNGRRanger Energy Services, Inc.$294.6M67
AESIAtlas Energy Solutions, Inc.$690.6M4

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Core Laboratories, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CLB news & analysis

CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions

Zacks Investment Research · 3 Nov 2026negative

Core Laboratories reported Q3 earnings below estimates amid rising costs and geopolitical disruptions, despite revenue exceeding estimates and stronger international lab activity.

Why it matters — CLB watchers may note the earnings shortfall alongside the revenue beat and stronger international lab activity.

Core Laboratories Q3 Earnings Call Highlights

MarketBeat · 30 Oct 2026neutral

Core Laboratories reported higher third-quarter revenue, operating income, and earnings per share compared with the prior quarter. Geopolitical disruptions in the Middle East and Russia-Ukraine continued to constrain parts of its international services business.

Why it matters — The results show sequential improvement alongside ongoing geopolitical constraints on some international services.

Core Laboratories Inc. (CLB) Q3 2026 Earnings Call Transcript

Seeking Alpha · 29 Oct 2026neutral

Core Laboratories held its Q3 2026 earnings conference call on October 29, 2026. The excerpt lists company and analyst participants and notes that the call was recorded.

Why it matters — The call is an opportunity for CLB watchers to hear management discuss the quarter, but the provided excerpt contains no financial results or business commentary.

Core Laboratories (CLB) Q3 Earnings Miss Estimates

Zacks Investment Research · 29 Oct 2026negative

Core Laboratories reported Q3 earnings of $0.16 per share, below the Zacks Consensus Estimate of $0.17. Earnings were $0.22 per share in the year-ago quarter.

Why it matters — CLB watchers may note the quarterly earnings miss and the year-over-year decline in per-share earnings.

CORE LAB REPORTS THIRD QUARTER 2026 RESULTS:

PRNewsWire · 28 Oct 2026neutral

Core Laboratories reported third-quarter 2026 revenue of $132.1 million and GAAP operating income of $12.1 million, with diluted EPS of $0.12. Revenue rose 6% sequentially but fell 2% year over year; the company also reported $1.7 million in free cash flow, repurchased 87,873 shares, and announced a fourth-quarter dividend.

Why it matters — The release gives CLB watchers current revenue, earnings, cash-flow, and shareholder-return figures, with key measures showing mixed sequential and year-over-year comparisons.

FAQ

Frequently asked questions about CLB stock

What is the CLB stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Core Laboratories, Inc. have a median 12-month price target of $13, with estimates ranging from $11 to $21. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CLB stock a buy right now?

Of the 3 analysts covering Core Laboratories, Inc., 2 rate it a Buy, 0 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Core Laboratories, Inc. 38 out of 100 across roughly 4,600 US stocks as at 14 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CLB?

As at 14 Nov 2026, Core Laboratories, Inc. ranks 38 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (87 of 100).

Will CLB stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +53.8% from the last close, and Ticker Nerd's factor model ranks Core Laboratories, Inc. 38 out of 100 as at 14 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CLB stock forecast for 2030?

No analyst covering Core Laboratories, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $21 over the next 12 months.

How has CLB stock performed over the past year?

Core Laboratories, Inc. returned -44.9% over the 12 months to 16 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Core Laboratories, Inc. do?

Core Laboratories Inc. is an oilfield services company that provides specialized reservoir description and production enhancement services and products to the oil and gas industry.

What is the latest news on CLB?

The most recent item we track (Zacks Investment Research, 3 Nov 2026): "CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions". Core Laboratories reported Q3 earnings below estimates amid rising costs and geopolitical disruptions, despite revenue exceeding estimates and stronger international lab activity.

Company

About Core Laboratories, Inc.

Core Laboratories Inc. is an oilfield services company that provides specialized reservoir description and production enhancement services and products to the oil and gas industry. Core Laboratories Inc. helps customers evaluate reservoir rock and fluid properties, improve well performance, and increase recovery from new and existing fields through laboratory analysis, field services, and proprietary technologies. Its business is organized into Reservoir Description and Production Enhancement, two complementary segments that support exploration, development, and production decisions. The company serves major, national, and independent oil companies across international markets, with operations in more than 50 countries. Core Laboratories Inc. also applies its technical expertise to subsurface evaluation work related to carbon capture and sequestration projects, reflecting its role in advanced energy and reservoir analysis.

CEO Mr. Lawrence V. Bruno · 3,300 employees · United States · https://www.corelab.com